A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO ASSESS SAFETY AND EFFICACY OF SLS-005 (TREHALOSE INJECTION, 90.5 MG/ML FOR INTRAVENOUS INFUSION) FOR THE TREATMENT OF ADULTS WITH SPINOCEREBELLAR ATAXIA

  • Bertram, Kelly (Primary Chief Investigator (PCI))
  • Paynter, Camille (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date28/07/22 → 2/12/24

Keywords

  • clinical trial
  • Spinocerebellar ataxia
  • Trehalose
  • neurodegenerative disorders